Transdermal Peptide - 1 mg
- Cat.Number : AS-62066
- Manufacturer Ref. :
-
Availability :
In stock
This short synthetic peptide facilitates efficient transdermal protein drug delivery through intact skin. Co-administration of the peptide and insulin to the abdominal skin of diabetic rats results in elevated systemic levels of insulin and suppresses serum glucose levels. This peptide creates a transient opening in the skin barrier to enable macromolecular drugs to reach systemic circulation.
Specifications
Chemistry | |
Sequence one letter code |
|
---|---|
Sequence three letter code |
|
Molecular Formula |
|
Molecular Mass/ Weight |
|
Modification | |
Conjugation |
|
Quantity & Purity | |
Purity |
|
Storage & stability | |
Form |
|
Storage Conditions |
|
Activity | |
Biomarker Target | |
Research Area | |
Sub-category Research Area | |
Usage |
|
Codes | |
Code Nacres |
|
You may also be interested in the following product(s)
![Tube of (Arg)9 peptide](/assets/cache/bb13e446-9489-4949-8618-2e610216715f/500x500/as-61204-img-en-as-61204-01.jpg)
![Tube of FITC-LC-Antennapedia Peptide](/assets/cache/a683681d-fa3d-44b6-9f51-933bd088256d/500x500/as-24175-img-en-as-24175-01.jpg)
![Tube of TAT (47-57) peptide, TAMRA-labeled](/assets/cache/80e3f5d7-2ed7-4bb6-9857-b716c0b72fbd/500x500/as-61211-img-en-as-61211-01.jpg)
Citations
Effective siRNA delivery and target mRNA degradation using an amphipathic peptide to facilitate pH-dependent endosomal escape
Biochem J. . 2011 Apr 15 ; 435(2) 475 | DOI : 10.1042/BJ20101021
- R. Bartz
- et al